-
1دورية أكاديمية
المؤلفون: Franz Kricek, Christine Ruf, Premji Meghani, Ivana A. Souza, Maria A. Gandini, Gerald W. Zamponi, George Skouteris
المصدر: Biomedicine & Pharmacotherapy, Vol 174, Iss , Pp 116472- (2024)
مصطلحات موضوعية: Chronic Pain, VGCC, CACNA2D1, Gabapentinoids, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S0753332224003561Test; https://doaj.org/toc/0753-3322Test
-
2رسالة جامعية
المؤلفون: Gu, Xinchun
المساهمون: Chen, Teng-Chou, Chen, Li-Chia, Steinke, Douglas
مصطلحات موضوعية: gabapentinoids, chronic pain, serious adverse events, drug utilisation
-
3دورية أكاديمية
المؤلفون: Louise Durand, Eamon Keenan, Deirdre O’Reilly, Kathleen Bennett, Andy O’Hara, Gráinne Cousins
المصدر: BMC Psychiatry, Vol 23, Iss 1, Pp 1-12 (2023)
مصطلحات موضوعية: Prison prescribing, Prescription opioids, Benzodiazepines, Z-drugs, Gabapentinoids, Opioid use disorder, Psychiatry, RC435-571
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1471-244XTest
-
4دورية أكاديمية
المؤلفون: Glancy, Megan, Palmateer, Norah, Yeung, Alan, Hickman, Matthew, Macleod, John, Bishop, Jen, Barnsdale, Lee, Trayner, Kirsten M. A., Priyadarshi, Saket, Wallace, Jason, Hutchinson, Sharon, McAuley, Andrew
المصدر: Glancy , M , Palmateer , N , Yeung , A , Hickman , M , Macleod , J , Bishop , J , Barnsdale , L , Trayner , K M A , Priyadarshi , S , Wallace , J , Hutchinson , S & McAuley , A 2024 , ' Risk of drug-related death associated with co-prescribing of gabapentinoids and Z-drugs among people receiving opioid-agonist treatment: a national retrospective cohort study ' , Psychiatry Research , vol. 339 , 116028 . https://doi.org/10.1016/j.psychres.2024.116028Test
مصطلحات موضوعية: Substance use disorder, Opioid use disorder, Opioid-agonist treatment, Methadone, Buprenorphine, Mortality, Sedatives, Gabapentinoids, Z-drugs, Overdose, /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, name=SDG 3 - Good Health and Well-being, /dk/atira/pure/subjectarea/asjc/2700/2738, name=Psychiatry and Mental health, /dk/atira/pure/subjectarea/asjc/2800/2803, name=Biological Psychiatry
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1016/j.psychres.2024.116028Test
https://researchonline.gcu.ac.uk/en/publications/ba5e6f17-44e5-4f0b-82bb-7201edd7d7dfTest
https://researchonline.gcu.ac.uk/ws/files/90255251/87844189.pdfTest -
5دورية أكاديمية
المؤلفون: O. I. Butranova, S. K. Zyryanov, О. И. Бутранова, С. К. Зырянов
المساهمون: This review work was supported by Viatris. The sponsor had no influence on the selection of material for the publication, the data analysis and interpretation., Обзорная работа выполнена при поддержке компании Виатрис. Спонсор не оказывал влияния на выбор материала для публикации, анализ и интерпретацию данных.
المصدر: Pharmacy & Pharmacology; Том 1, № 1 (2024); 74-88 ; Фармация и фармакология; Том 1, № 1 (2024); 74-88 ; 2413-2241 ; 2307-9266 ; 10.19163/2307-9266-2024-1-1
مصطلحات موضوعية: хроническая боль, gabapentinoids, neuropathic pain, diabetic polyneuropathy, postherpetic neuralgia, chronic pain, габапентиноиды, нейропатическая боль, диабетическая полинейропатия, постгерпетическая невралгия
وصف الملف: application/pdf
العلاقة: https://www.pharmpharm.ru/jour/article/view/1452/1029Test; https://www.pharmpharm.ru/jour/article/view/1452/1030Test; Scholz J., Finnerup N.B., Attal N., Aziz Q., Baron R., Bennett M.I., Benoliel R., Cohen M., Cruccu G., Davis K.D., Evers S., First M., Giamberardino M.A., Hansson P., Kaasa S., Korwisi B., Kosek E., Lavand’homme P., Nicholas M., Nurmikko T., Perrot S., Raja S.N., Rice A.S.C., Rowbotham M.C., Schug S., Simpson D.M., Smith B.H., Svensson P., Vlaeyen J.W.S., Wang S.J., Barke A., Rief W., Treede R.D.; Classification Committee of the Neuropathic Pain Special Interest Group (NeuPSIG). The IASP classification of chronic pain for ICD-11: chronic neuropathic pain // Pain. – 2019. – Vol. 160, No. 1. – P. 53–59. DOI:10.1097/j.pain.0000000000001365; Cavalli E., Mammana S., Nicoletti F., Bramanti P., Mazzon E. The neuropathic pain: An overview of the current treatment and future therapeutic approaches // Int J Immunopathol Pharmacol. – 2019. – Vol. 33. – Art. ID: 2058738419838383. DOI:10.1177/2058738419838383; van Velzen M, Dahan A, Niesters M. Neuropathic Pain: Challenges and Opportunities // Front Pain Res (Lausanne). – 2020. – Vol. 1. – Art. ID: 1. DOI:10.3389/fpain.2020.00001; Baskozos G., Hébert H.L., Pascal M.M., Themistocleous A.C., Macfarlane G.J., Wynick D., Bennett D.L., Smith B.H. Epidemiology of neuropathic pain: an analysis of prevalence and associated factors in UK Biobank // Pain Rep. – 2023. – Vol. 8, No. 2. – P. e1066. DOI:10.1097/PR9.0000000000001066; Медведева Л.А., Загорулько О.И. Результаты анализа обращений пациентов и их финансирования в Клинике изучения и лечения боли за последнее десятилетие // Российский журнал боли. – 2022. – Т. 20, № 4. – С. 45–50. DOI:10.17116/pain20222004145; Воробьёва Н.М., Маневич Т.М., Ткачёва О.Н., Котовская Ю.В., Селезнёва Е.В., Овчарова Л.Н. Распространённость и особенности хронического болевого синдрома у лиц старше 65 лет: данные российского эпидемиологического исследования ЭВКАЛИПТ // Российский журнал гериатрической медицины. – 2021. – № 4. – С. 425–434. DOI:10.37586/2686-8636-4-2021-425-434; Cherif F., Zouari H.G., Cherif W., Hadded M., Cheour M., Damak R. Depression prevalence in neuropathic pain and its impact on the quality of life // Pain Res Manag. – 2020. – Vol. 2020. – Art. ID: 7408508. DOI:10.1155/2020/7408508; Li K.L., Chen Y.M., Wang X.Q., Hu H.Y. Bibliometric analysis of studies on neuropathic pain associated with depression or anxiety published from 2000 to 2020 // Front Hum Neurosci. – 2021. – Vol. 15. – Art. ID: 729587. DOI:10.3389/fnhum.2021.729587; Guntel M., Huzmeli E.D., Melek I. Patients with neuropathic pain have poor sleep quality // J Nerv Ment Dis. – 2021. – Vol. 209, No. 7. – P. 505–509. DOI:10.1097/NMD.0000000000001325; Bekircan-Kurt C.E., Inan B., Bulut O., Şengün İ., Karli N., Güneş N., Çokal B.G., Güler S.K., Yoldaş T.K., Özcanyüz D.G., Koç F., Ünlütürk Z., Erdoğan Ç., Uludağ B., Boz C., Tütüncü M., Akalin M.A., Kamişli Ö., Özcan A., Koytak P.K., Uluç K., Erdem-Özdamar S., Tan E. Neuropathic pain frequency in neurology outpatients: A multicenter study // Noro Psikiyatr Ars. – 2021. – Vol. 58, No. 4. – P. 257–260. DOI:10.29399/npa.27549; DiBonaventura M.D., Sadosky A., Concialdi K., Hopps M., Kudel I., Parsons B., Cappelleri J.C., Hlavacek P., Alexander A.H., Stacey B.R., Markman J.D., Farrar J.T. The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health survey // J Pain Res. – 2017. – Vol. 10. – P. 2525–2538. DOI:10.2147/JPR.S127014; Cragg J.J., Noonan V.K., Noreau L., Borisoff J.F., Kramer J.K. Neuropathic pain, depression, and cardiovascular disease: a national multicenter study // Neuroepidemiology. – 2015. – Vol. 44, No. 3. – P. 130–137. DOI:10.1159/000377726; Liedgens H., Obradovic M., De Courcy J., Holbrook T., Jakubanis R. A burden of illness study for neuropathic pain in Europe // Clinicoecon Outcomes Res. – 2016. – Vol. 8. – P. 113–126. DOI:10.2147/CEOR.S81396; Соловьева Э.Ю., Амелина И.П., Плиева Э.К. Индивидуальный подход медикаментозной коррекции пациентов с нейропатической болью // Лечащий Врач. 2022. – № 12. – С. 86–94. DOI:10.51793/OS.2022.25.12.014; Бородулина И.В., Рачин А.П. Патогенетические подходы к терапии обострения хронической боли в спине: описание клинического случая // Медицинский совет. – 2019. – № 12. – С. 42–47. DOI:10.21518/2079-701X-2019-12-42-47; Schlereth T. Guideline “diagnosis and non interventional therapy of neuropathic pain” of the German Society of Neurology (deutsche Gesellschaft für Neurologie) // Neurol Res Pract. – 2020. – Vol. 2. – Art. ID: 16. DOI:10.1186/s42466-020-00063-3; Давыдов О.С., Яхно Н.Н., Кукушкин М.Л. Чурюканов М.В., Абузарова Г.Р., Амелин А.В., Балязин В.А., Баранцевич Е.Р., Баринов А.Н., Барулин А.Е., Бельская Г.Н., Быков Ю.Н., Данилов А.Б., Доронина О.Б., Древаль О.Н., Евсеев М.А., Загорулько О.И., Исагулян Э.Д., Калинский П.П., Каракулова Ю.В., Каратеев А.Е., Копенкин С.С., Курушина О.В., Медведева Л.А., Парфенов В.А., Сергиенко Д.А., Строков И.А., Хабиров Ф.А., Широков В.А. Невропатическая боль. – Art. ID: клинические рекомендации по диагностике и лечению Российского общества по изучению боли // Российский журнал боли. – 2018. – Т. 4, № 58. – С. 5-41. DOI:10.25731/RASP.2018.04.025; Сорокина Н.Д., Перцов С.С., Селицкий Г.В., Жердева А.С. Противоэпилептические препараты в лечении мигрени и невропатической боли // Российский журнал боли. – 2021. – Т. 19, № 3. – С. 45–52. DOI:10.17116/pain20211903145; Bates D., Schultheis B.C., Hanes M.C., Jolly S.M., Chakravarthy K.V., Deer T.R., Levy R.M., Hunter C.W. A Comprehensive algorithm for management of neuropathic pain // Pain Med. – 2019. – Vol. 20, Suppl 1. – P. S2–S12. DOI:10.1093/pm/pnz075. Erratum in: // Pain Med. – 2023. – Vol. 24, No. 2. – Art. ID: 219.; Cui C.X., Liu H.Y., Yue N., Du Y.R., Che L.M., Yu J.S. Research progress on the mechanism of chronic neuropathic pain // IBRO Neurosci Rep. – 2022. – Vol. 14. – P. 80–85. DOI:10.1016/j.ibneur.2022.12.007; Hamdan A., Galvez R., Katati M. Shedding light on neuropathic pain: Current and emerging tools for diagnosis, screening, and quantification // SAGE Open Med. – 2024. – Vol. 12. – Art. ID: 20503121231218985. DOI:10.1177/20503121231218985; Deng M., Chen S.R., Pan H.L. Presynaptic NMDA receptors control nociceptive transmission at the spinal cord level in neuropathic pain // Cell Mol Life Sci. – 2019. – Vol. 76, No. 10. – P. 1889–1899. DOI:10.1007/s00018-019-03047-y; Huang Y., Chen H., Jin D., Chen S.R., Pan H.L. NMDA receptors at primary afferent-excitatory neuron synapses differentially sustain chemotherapy- and nerve trauma-induced chronic pain // J Neurosci. – 2023. – Vol. 43, No. 21. – P. 3933–3948. DOI:10.1523/JNEUROSCI.0183-23.2023; Wang L., Chen S.R., Ma H., Chen H., Hittelman W.N., Pan H.L. Regulating nociceptive transmission by VGluT2-expressing spinal dorsal horn neurons // J Neurochem. – 2018. – Vol. 147, No. 4. – P. 526–540. DOI:10.1111/jnc.14588; Taylor C.P., Harris E.W. Analgesia with gabapentin and pregabalin may involve n-methyl-d-aspartate receptors, neurexins, and thrombospondins // J Pharmacol Exp Ther. – 2020. – Vol. 374, No. 1. – P. 161–174. DOI:10.1124/jpet.120.266056; Varadi G. Mechanism of analgesia by gabapentinoid drugs: Involvement of modulation of synaptogenesis and trafficking of glutamate-gated ion channels // J Pharmacol Exp Ther. – 2024. – Vol. 388, No. 1. – P. 121–133. DOI:10.1124/jpet.123.001669; Russo M., Graham B., Santarelli D.M. Gabapentin-Friend or foe? // Pain Pract. – 2023. – Vol. 23, No. 1. – P. 63–69. DOI:10.1111/papr.13165; Wu T., Chen S.R., Pan H.L., Luo Y. The α2δ-1-NMDA receptor complex and its potential as a therapeutic target for ischemic stroke // Front Neurol. – 2023. – Vol. 14. – Art. ID: 1148697. DOI:10.3389/fneur.2023.1148697; Papassidero P., Wichert-Ana L., Lia E.N., Alexandre- Santos L., Trevisan A.C., Coelho E.B., Della Pasqua O., Lanchote V.L., Dach F. Pharmacodynamic effect of gabapentin on central nervous system in patients with chronic low back pain: a [99mTc]Tc-ECD SPECT study // Reg Anesth Pain Med. – 2023. – Vol. 48, No. 8. – P. 408–413. DOI:10.1136/rapm-2022-104047; Fuller-Bicer G.A., Varadi G., Koch S.E., Ishii M., Bodi I., Kadeer N., Muth J.N., Mikala G., Petrashevskaya N.N., Jordan M.A., Zhang S.P., Qin N., Flores C.M., Isaacsohn I., Varadi M., Mori Y., Jones W.K., Schwartz A. Targeted disruption of the voltage-dependent calcium channel alpha2/delta-1-subunit // Am J Physiol Heart Circ Physiol. – 2009. – Vol. 297, No. 1. – P. 117–124. DOI:10.1152/ajpheart.00122.2009; Manville R.W., Abbott G.W. Gabapentin Is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels // Mol Pharmacol. – 2018. – Vol. 94, No. 4. – P. 1155–1163. DOI:10.1124/mol.118.112953; Yu J., Wang D.S., Bonin R.P., Penna A., Alavian- Ghavanini A., Zurek A.A., Rauw G., Baker G.B., Orser B.A. Gabapentin increases expression of δ subunit-containing GABAA receptors // EBioMedicine. – 2019. – Vol. 42. P. 203–213. DOI:10.1016/j.ebiom.2019.03.008; Hayashida K.I., Obata H. Strategies to Treat Chronic Pain and Strengthen Impaired Descending Noradrenergic Inhibitory System // Int J Mol Sci. – 2019. – Vol. 20, No. 4. – P. 822. DOI:10.3390/ijms20040822; Chincholkar M. Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice // Br J Pain. – 2020. – Vol. 14, No. 2. – P. 104–114. DOI:10.1177/2049463720912496; Lal R., Ellenbogen A., Gidal B. Interindividual variability in the bioavailability of gabapentin enacarbil extended release in healthy adults: An analysis of data from 6 phase I studies // Ther Drug Monit. – 2022. – Vol. 44, No. 3. – P. 448–454. DOI:10.1097/FTD.0000000000000935; Dickens D., Webb S.D., Antonyuk S., Giannoudis A., Owen A., Rädisch S., Hasnain S.S., Pirmohamed M. Transport of gabapentin by LAT1 (SLC7A5) // Biochem Pharmacol. – 2013. – Vol. 85, No. 11. – P. 1672–1683. DOI:10.1016/j.bcp.2013.03.022; Bockbrader H.N., Wesche D., Miller R., Chapel S., Janiczek N., Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin // Clin Pharmacokinet. – 2010. – Vol. 49, No. 10. – P. 661–669. DOI:10.2165/11536200-000000000-00000; Ahmed G.F., Bathena S.P., Brundage R.C., Leppik I.E., Conway J.M., Schwartz J.B., Birnbaum A.K. Pharmacokinetics and saturable absorption of gabapentin in nursing home elderly patients // AAPS J. – 2017. – Vol. 19, No. 2. – P. 551–556. DOI:10.1208/s12248-016-0022-z; Costa A.C.C., de Lima Benzi J.R., Yamamoto P.A., de Freitas M.C.F., de Paula F.J.A., Zanelli C.F., Lauretti G.R., de Moraes N.V. Population pharmacokinetics of gabapentin in patients with neuropathic pain: Lack of effect of diabetes or glycaemic control // Br J Clin Pharmacol. – 2021. – Vol. 87, No. 4. – P. 1981–1989. DOI:10.1111/bcp.14594; Lindberger M., Luhr O., Johannessen S.I., Larsson S., Tomson T. Serum concentrations and effects of gabapentin and vigabatrin: observations from a dose titration study // Ther Drug Monit. – 2003. – Vol. 25, No. 4. – P. 457–462. DOI:10.1097/00007691-200308000-00007; Gidal B.E., DeCerce J., Bockbrader H.N., Gonzalez J., Kruger S., Pitterle M.E., Rutecki P., Ramsay R.E. Gabapentin bioavailability: effect of dose and frequency of administration in adult patients with epilepsy // Epilepsy Res. – 1998. – Vol. 31, No. 2. – P. 91–99. DOI:10.1016/s0920-1211(98)00020-5; Quintero G.C. Review about gabapentin misuse, interactions, contraindications and side effects // J Exp Pharmacol. – 2017. – Vol. 9. – P. 13–21. DOI:10.2147/JEP.S124391; Yagi T., Naito T., Mino Y., Umemura K., Kawakami J. Impact of concomitant antacid administration on gabapentin plasma exposure and oral bioavailability in healthy adult subjects // Drug Metab Pharmacokinet. – 2012. – Vol. 27, No. 2. – P. 248–254. DOI:10.2133/dmpk.dmpk-11-rg-108; Gomes T., Juurlink D.N., Antoniou T., Mamdani M.M., Paterson J.M., van den Brink W. Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study // PLoS Med. – 2017. – Vol. 14, No. 10. – P. e1002396. DOI:10.1371/journal.pmed.1002396; Singh H., Handa R., Kak V., Wasilewski A. Complex encephalopathy arising from the combination of opioids and gabapentin // BMJ Case Rep. – 2019. – Vol. 12, No. 4. – P. e228354. DOI:10.1136/bcr-2018-228354; Wiffen P.J., Derry S., Bell R.F., Rice A.S., Tölle T.R., Phillips T., Moore R.A. Gabapentin for chronic neuropathic pain in adults // Cochrane Database Syst Rev. – 2017. – Vol. 6, No. 6. – P. CD007938. DOI:10.1002/14651858.CD007938.pub4; Davari M., Amani B., Amani B., Khanijahani A., Akbarzadeh A., Shabestan R. Pregabalin and gabapentin in neuropathic pain management after spinal cord injury: a systematic review and meta-analysis // Korean J Pain. – 2020. – Vol. 33, No. 1. – P. 3–12. DOI:10.3344/kjp.2020.33.1.3; Tong C., Zhengyao Z., Mei L., Dongpo S., Qian H., Fengqun M. Pregabalin and gabapentin in patients with spinal cord injury-related neuropathic pain: A network meta-analysis // Pain Ther. – 2021. – Vol. 10, No. 2. – P. 1497–1509. DOI:10.1007/s40122-021-00302-8; Ko Y.C., Lee C.H., Wu C.S., Huang Y.J. Comparison of efficacy and safety of gabapentin and duloxetine in painful diabetic peripheral neuropathy: A systematic review and meta-analysis of randomised controlled trials // Int J Clin Pract. – 2021. – Vol. 75. – P. e14576. DOI:10.1111/ijcp.14576; Meaadi J., Obara I., Eldabe S., Nazar H. The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials // Int J Clin Pharm. – 2023. – Vol. 45, No. 3. – P. 556–565. DOI:10.1007/s11096-022-01528-y; Cao X., Shen Z., Wang X., Zhao J., Liu W., Jiang G. A meta-analysis of randomized controlled trials comparing the efficacy and safety of pregabalin and gabapentin in the treatment of postherpetic neuralgia // Pain Ther. – 2023. – Vol. 12, No. 1. – P. 1–18. DOI:10.1007/s40122-022-00451-4; Shetty A., Delanerolle G., Cavalini H., Deng C., Yang X., Boyd A., Fernandez T., Phiri P., Bhaskar A., Shi J.Q. A systematic review and network meta-analysis of pharmaceutical interventions used to manage chronic pain // Sci Rep. – 2024. – Vol. 14, No. 1. – P. 1621. DOI:10.1038/s41598-023-49761-3; Sadegh A.A., Gehr N.L., Finnerup N.B. A systematic review and meta-analysis of randomized controlled head-to-head trials of recommended drugs for neuropathic pain // PAIN Reports. – 2024. – Vol. 9, No. 2. – P. e1138. DOI:10.1097/PR9.0000000000001138; Backonja M., Glanzman R.L. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials // Clin Ther. – 2003. – Vol. 25, No. 1. – P. 81–104. DOI:10.1016/s0149-2918, No. 03)90011-7; Zhang L., Rainka M., Freeman R., Harden R.N., Bell C.F., Chen C., Graff O., Harding K., Hunter S., Kavanagh S., Laurijssens B., Schwartzbach C., Warren S., McClung C. A randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (PXN110748) // J Pain. – 2013. – Vol. 14, No. 6. – P. 590–603. DOI:10.1016/j.jpain.2013.01.768; Cowles V.E., Gordi T., Hou S.Y. Steady-state pharmacokinetics of gabapentin after administration of a novel gastroretentive extended-release formulation in postmenopausal women with vasomotor symptoms // Clin Drug Investig. – 2012. – Vol. 32, No. 9. – P. 593–601. DOI:10.1007/BF0326191; Wang J., Zhu Y. Different doses of gabapentin formulations for postherpetic neuralgia: A systematical review and meta-analysis of randomized controlled trials // J Dermatolog Treat. – 2017. – Vol. 28, No. 1. – P. 65–77. DOI:10.3109/09546634.2016.1163315; Finnerup N.B., Attal N., Haroutounian S., McNicol E., Baron R., Dworkin R.H., Gilron I., Haanpää M., Hansson P., Jensen T.S., Kamerman P.R., Lund K., Moore A., Raja S.N., Rice A.S., Rowbotham M., Sena E., Siddall P., Smith B.H., Wallace M. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis // Lancet Neurol. – 2015. – Vol. 14, No. 2. – P. 162–173. DOI:10.1016/S1474-4422, No. 14)70251-0; Xiao H., Ma K., Huang D., Liu X.G., Liu T.H., Liu Q., Liu G.Z., Song T., Tao W., Wu D.S., Wang Y.X., Yang X.Q., Zhang X.M., Liu H., Liu Y.Q. Expert consensus of the Chinese Association for the Study of Pain on ion channel drugs for neuropathic pain // World J Clin Cases. – 2021. – Vol. 9, No. 9. – P. 2100–2109. DOI:10.12998/wjcc.v9.i9.2100; Ma K., Cheng Z., Jiang H., Lin Z., Liu C., Liu X., Lu L., Lu Y., Tao W., Wang S., Yang X., Yi Q., Zhang X., Zhang Y., Liu Y. Expert consensus on ion channel drugs for chronic pain treatment in China // J Pain Res. 2024 Mar 8. – Vol. 17. – P. 953–963. DOI:10.2147/JPR.S445171; Expert Group on Pain Disease Diagnosis and Treatment Special Ability Training Project of National Health Commission Capacity Building and Continuing Education Center. [Chinese guidelines for the treatment of chronic pain disorders with non-opioid analgesics] // Zhonghua Yi Xue Za Zhi. – 2023. – Vol. 103, No. 39. – P. 3088–3102. Chinese. DOI:10.3760/cma.j.cn112137-20230529-00876; Saxena A.K., Jain P., Dureja G.P., Venkitachalam A., Goswami S., Usmani H., Kothari S., Sahu D., Singh B., Trivedi V., Sharma G., Kamble S., Qamra A., Motlekar S., Jain R. Pharmacological management of neuropathic pain in India: A consensus statement from Indian experts // Indian Journal of Pain. – 2018. – Vol. 32, No. 3. – P. 132–144. DOI:10.4103/ijpn.ijpn_47_18; Price R., Smith D., Franklin G., Gronseth G., Pignone M., David W.S., Armon C., Perkins B.A., Bril V., Rae-Grant A., Halperin J., Licking N., O’Brien M.D., Wessels S.R., MacGregor L.C., Fink K., Harkless L.B., Colbert L., Callaghan B.C. Oral and topical treatment of painful diabetic polyneuropathy: Practice Guideline Update Summary: Report of the AAN Guideline Subcommittee // Neurology. – 2022. – Vol. 98, No. 1. – P. 31–43. DOI:10.1212/WNL.0000000000013038; Pop-Busui R., Boulton A.J., Feldman E.L., Bril V., Freeman R., Malik R.A., Sosenko J.M., Ziegler D. Diabetic Neuropathy: A Position Statement by the American Diabetes Association // Diabetes Care. – 2017. – Vol. 40, No. 1. – P. 136–154. DOI:10.2337/dc16-2042; Moisset X., Bouhassira D., Avez Couturier J., Alchaar H., Conradi S., Delmotte M.H., Lanteri-Minet M., Lefaucheur J.P., Mick G., Piano V., Pickering G., Piquet E., Regis C., Salvat E., Attal N. Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations // Rev Neurol (Paris). – 2020. – Vol. 176, No. 5. – P. 325-352. DOI:10.1016/j.neurol.2020.01.361; Галстян Г.Р., Старостина Е.Г., Яхно Н.Н., Гурьева И.В., Чурюканов М.В., Строков И.А., Токмакова А.Ю., Кукушкин М.Л., Мартынов А.И., Шестакова М.В. Диагностика и рациональная терапия болевой формы диабетической периферической нейропатии: междисциплинарный консенсус экспертов // Сахарный диабет. – 2019. – Т. 22, № 4. – С. 305–327. DOI:10.14341/DM9625; Ziegler D., Keller J., Maier C., Pannek J. Diabetic Neuropathy // Exp Clin Endocrinol Diabetes. – 2021. – Vol. 129, No. S 01. – P. S70–S81. DOI:10.1055/a-1284-6245; Loh E., Mirkowski M., Agudelo A.R., Allison D.J., Benton B., Bryce T.N., Guilcher S., Jeji T., Kras-Dupuis A., Kreutzwiser D., Lanizi O., Lee-Tai-Fuy G., Middleton J.W., Moulin D.E., O’Connell C., Orenczuk S., Potter P., Short C., Teasell R., Townson A., Widerström-Noga E., Wolfe D.L., Xia N., Mehta S. The CanPain SCI clinical practice guidelines for rehabilitation management of neuropathic pain after spinal cord injury: 2021 update // Spinal Cord. – 2022. – Vol. 60, No. 6. – P. 548–566. DOI:10.1038/s41393-021-00744-z; Lambru G., Zakrzewska J., Matharu M. Trigeminal neuralgia: a practical guide // Pract Neurol. – 2021. – Vol. 21, No. 5. – P. 392–402. DOI:10.1136/practneurol-2020-002782; Lennox R., Mangin D. Gabapentin misuse // CMAJ. – 2019. – Vol. 191, No. 2. – P. E47. DOI:10.1503/cmaj.180599; Mattson C.L., Chowdhury F., Gilson T.P. Notes from the field: trends in gabapentin detection and involvement in drug overdose deaths – 23 States and the District of Columbia, 2019-2020 // MMWR Morb Mortal Wkly Rep. – 2022. – Vol. 71, No. 19. – P. 664–666. DOI:10.15585/mmwr.mm7119a3; Finlayson G., Chavarria M., Chang S., Gardner T., Grande A., MacCallum C., deJong J.L., Quesnelle K. Gabapentin in mixed drug fatalities: Does this frequent analyte deserve more attention? // Acad Forensic Pathol. – 2017. – Vol. 7, No. 1. – P. 99–111. DOI:10.23907/2017.012; Smith R.V., Havens J.R., Walsh S.L. Gabapentin misuse, abuse and diversion: a systematic review // Addiction. – 2016. – Vol. 111, No. 7. – P. 1160–1174. DOI:10.1111/add.13324; Qiu X., Tackett E., Khitan Z. A case of gabapentin overdose induced rhabdomyolysis requiring renal replacement therapy // Clin Case Rep. – 2019. – Vol. 7, No. 8. – P. 1596–1599. DOI:10.1002/ccr3.2302; Zhang M., Gao C.X., Ma K.T., Li L., Dai Z.G., Wang S., Si J.Q. A meta-analysis of therapeutic efficacy and safety of gabapentin in the treatment of postherpetic neuralgia from randomized controlled trials // Biomed Res Int. – 2018. – Vol. 2018. P. 7474207. DOI:10.1155/2018/7474207; Straube S., Derry S., McQuay H.J., Moore R.A. Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review // Br J Clin Pharmacol. – 2008. – Vol. 66, No. 2. – P. 266–275. DOI:10.1111/j.1365-2125.2008.03200.x; Wei Y.J., Shrestha N., Chiang C., DeKosky S.T. Prevalence and trend of central nervous system-active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi-year cross-sectional study // Alzheimers Res Ther. – 2024. – Vol. 16, No. 1. – P. 30. DOI:10.1186/s13195-024-01405-y; Сычев Д.А., Отделёнов В.А., Краснова Н.М., Ильина Е.С. Полипрагмазия: взгляд клинического фармаколога // Терапевтический архив. – 2016. – Т. 88, № 12. – С. 94–102. DOI:10.17116/terarkh2016881294-102; Glerum P.J., Yamada W.M., Neely M.N., Burger D.M., Maliepaard M., Neef C. Interchangeability of generic drugs for subpopulations: Bioequivalence simulation from a nonparametric PK model of gabapentin generic drugs // Br J Clin Pharmacol. – 2022. DOI:10.1111/bcp.15629.; https://www.pharmpharm.ru/jour/article/view/1452Test
الإتاحة: https://doi.org/10.19163/2307-9266-2024-12-1-74-88Test
https://doi.org/10.19163/2307-9266-2024-1-1Test
https://doi.org/10.1097/j.pain.0000000000001365Test
https://doi.org/10.1177/2058738419838383Test
https://doi.org/10.3389/fpain.2020.00001Test
https://doi.org/10.1097/PR9.0000000000001066Test
https://doi.org/10.17116/pain20222004145Test
https://doi.org/10.37586/2686-8636-4-2021-425-434Test
https://doi.org/10.1155/2020/7408508Test
https://doi.org/10.3389/fnhum.2021.729587Test -
6دورية أكاديمية
المصدر: Frontiers in Pharmacology, Vol 14 (2023)
مصطلحات موضوعية: lumbar spinal stenosis, pregabalin, gabapentin, gabapentinoids, treatment, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fphar.2023.1249478/fullTest; https://doaj.org/toc/1663-9812Test
-
7دورية أكاديمية
المؤلفون: Antunovic M, Vucinic S, Kotur-Stevuljevic J, Krstic K, Jovic-Stosic J, Kilibarda V, Perkovic-Vukcevic N, Djordjevic S
المصدر: International Journal of General Medicine, Vol Volume 16, Pp 1239-1250 (2023)
مصطلحات موضوعية: gabapentinoids, overdose, misuse, drug consumption, psychoactive substances, Medicine (General), R5-920
وصف الملف: electronic resource
-
8دورية أكاديمية
المؤلفون: William Raffaeli, Giorgio Felzani, Michael Tenti, Luca Greco, Maria Pia D’Eramo, Stefania Proietti, Giovanni Morone
المصدر: Healthcare, Vol 11, Iss 18, p 2563 (2023)
مصطلحات موضوعية: neuropathic pain, spinal cord injury, stroke, supplements, gabapentinoids, pregabalin, Medicine
وصف الملف: electronic resource
-
9دورية أكاديمية
المؤلفون: Zhao D, Baek J, Hume AL, McPhillips EA, Lapane KL
المصدر: Journal of Pain Research, Vol Volume 15, Pp 443-454 (2022)
مصطلحات موضوعية: gabapentinoids, opioids, pain, geographic variation, Medicine (General), R5-920
وصف الملف: electronic resource
العلاقة: https://www.dovepress.com/geographic-variation-in-the-use-ofTest-gabapentinoids-and-opioids-for-pain-peer-reviewed-fulltext-article-JPR; https://doaj.org/toc/1178-7090Test
-
10دورية أكاديمية
المؤلفون: Manami Yajima, Yukari Takahashi, Yae K. Sugimura, Fusao Kato
المصدر: Neurobiology of Pain, Vol 13, Iss , Pp 100131- (2023)
مصطلحات موضوعية: Gabapentinoids, Inflammation-induced widespread pain, von Frey filament test, Central sensitization, Ectopic sensitization, Orofacial inflammatory pain, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2452073X23000181Test; https://doaj.org/toc/2452-073XTest
النص الكامل